Betta Pharmaceuticals Co.,Ltd — Investor Relations & Filings
Betta Pharmaceuticals Co.,Ltd. focuses on the research, development, and commercialization of innovative oncology medications. The organization specializes in targeted therapies, particularly for the treatment of lung cancer and other solid tumors. Its portfolio includes Icotinib, a small-molecule EGFR tyrosine kinase inhibitor, and Ensartinib, an ALK inhibitor designed for non-small cell lung cancer. The company operates a comprehensive R&D infrastructure dedicated to molecular biology, medicinal chemistry, and clinical development. By prioritizing precision medicine, the firm aims to deliver high-quality therapeutic solutions that address complex oncological challenges. Its pipeline encompasses a diverse range of candidates, including small molecules and biologics, aimed at improving patient outcomes through advanced scientific innovation.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 董事会审计委员会关于对会计师事务所2024年度履职情况的评估报告 | 2025-04-17 | Chinese | |
| 关于“质量回报双提升”行动方案的进展公告 | 2025-04-17 | Chinese | |
| 2024年度独立董事述职报告（肖佳佳） | 2025-04-17 | Chinese | |
| 2024年年度财务决算报告 | 2025-04-17 | Chinese | |
| 2024年度非经营性资金占用及其他关联资金往来情况专项报告 | 2025-04-17 | Chinese | |
| 关于举行2024年度网上业绩说明会的公告 | 2025-04-17 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 37810766 | 董事会审计委员会关于对会计师事务所2024年度履职情况的评估报告 | 2025-04-17 | Chinese | ||
| 37810761 | 关于“质量回报双提升”行动方案的进展公告 | 2025-04-17 | Chinese | ||
| 37810746 | 2024年度独立董事述职报告（肖佳佳） | 2025-04-17 | Chinese | ||
| 37810730 | 2024年年度财务决算报告 | 2025-04-17 | Chinese | ||
| 37810717 | 2024年度非经营性资金占用及其他关联资金往来情况专项报告 | 2025-04-17 | Chinese | ||
| 37810697 | 关于举行2024年度网上业绩说明会的公告 | 2025-04-17 | Chinese | ||
| 37810675 | 贝达药业股份有限公司舆情管理制度（2025年4月） | 2025-04-17 | Chinese | ||
| 37810656 | 关于增加董事会成员人数并修订《公司章程》的公告 | 2025-04-17 | Chinese | ||
| 37810640 | 董事会审计委员会关于对会计师事务所2024年度履行监督职责情况的报告 | 2025-04-17 | Chinese | ||
| 37810623 | 董事会决议公告 | 2025-04-17 | Chinese | ||
| 37810592 | 贝达药业股份有限公司市值管理制度（2025年4月） | 2025-04-17 | Chinese | ||
| 37810577 | 2024年度独立董事述职报告（汪炜） | 2025-04-17 | Chinese | ||
| 37810564 | 2024年年度报告摘要 | 2025-04-17 | Chinese | ||
| 37810560 | 2024年度独立董事述职报告（JIANGNAN CAI） | 2025-04-17 | Chinese | ||
| 37810549 | 关于2024年度证券投资情况的专项说明 | 2025-04-17 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Betta Pharmaceuticals Co.,Ltd via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55541/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55541 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55541 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55541 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55541}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Betta Pharmaceuticals Co.,Ltd (id: 55541)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.